How big is the cell viability assays market?

Moreover cell Viability Assays and cytotoxicity assays are used for drug screening and cytotoxicity tests of chemicals.Market Analysis and Insights Global Cell Viability Assays MarketThe global Cell Viability Assays market size is projected to reach US 3580.6 million by 2028 from US 2506.8 million in 2021 at a CAGR of 4.8 during 20222028.Numerous factors such as growing prevalence of chronic and infectious diseases growing availability of funds for cellbased research rising need of cellbased assays in research and development activities are expected to drive the growth of the market.With industrystandard.

Who are the key players in the cell viability assays market?

Some of the key players are ThermoFisher Scientific, Merck, Bio Rad, GE, Danaher, BD, Perkin Elmer, Promega, Biotium, Abcam, Creative Bioarray, Biotek Instruments, Thermo Fisher Scientific, Merck, PerkinElmer Inc, Others.

Global Cell Viability Assays Market Insights and Forecast to 2028

BUY CHAPTERS

Global Cell Viability Assays Market Insights, Forecast to 2029

Code: QYRE-Othe-370

Report

May 2023

Pages:110

QYResearch

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

PerkinElmer Inc

Merck

Cell Viability Assays Market Size

The global Cell Viability Assays market is projected to grow from US$ 2702.6 million in 2023 to US$ 3580.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.

Cell Viability Assays Market

Cell Viability Assays is a type of technique used for determining viable cells in the culture. Cell Viability Assays asses the efficiency of the cells by measuring markers of cellular activity. The cell viability is used to monitor the response and health of the cells in the culture after treatment with various stimuli. Moreover, cell Viability Assays and cytotoxicity assays are used for drug screening and cytotoxicity tests of chemicals.

Market Analysis and Insights: Global Cell Viability Assays Market

Numerous factors such as growing prevalence of chronic and infectious diseases, growing availability of funds for cell-based research, rising need of cell-based assays in research and development activities are expected to drive the growth of the market.

Report Includes

This report presents an overview of global market for Cell Viability Assays market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Cell Viability Assays, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell Viability Assays, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell Viability Assays revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Cell Viability Assays market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Cell Viability Assays revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Merck, Bio-Rad, GE, Danaher, BD, PerkinElmer, Promega and Biotium, etc.

Scope of Cell Viability Assays Market Report

Report Metric	Details
Report Name	Cell Viability Assays Market
Accounted market size in 2023	US$ 2702.6 million
Forecasted market size in 2029	US$ 3580.6 million
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Human Cells Microbial Cells Animal Cells
Segment by Application	Pharmaceutical and Biotechnology Companies Academic and Research Institutes Hospital and Diagnostic Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Merck, Bio-Rad, GE, Danaher, BD, PerkinElmer, Promega, Biotium, Abcam, Creative Bioarray, Biotek Instruments
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell Viability Assays in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Viability Assays companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Viability Assays revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell Viability Assays Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Human Cells

1.2.3 Microbial Cells

1.2.4 Animal Cells

1.3 Market by Application

1.3.1 Global Cell Viability Assays Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Academic and Research Institutes

1.3.4 Hospital and Diagnostic Laboratories

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell Viability Assays Market Perspective (2018-2029)

2.2 Global Cell Viability Assays Growth Trends by Region

2.2.1 Cell Viability Assays Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Cell Viability Assays Historic Market Size by Region (2018-2023)

2.2.3 Cell Viability Assays Forecasted Market Size by Region (2024-2029)

2.3 Cell Viability Assays Market Dynamics

2.3.1 Cell Viability Assays Industry Trends

2.3.2 Cell Viability Assays Market Drivers

2.3.3 Cell Viability Assays Market Challenges

2.3.4 Cell Viability Assays Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Cell Viability Assays by Players

3.1.1 Global Cell Viability Assays Revenue by Players (2018-2023)

3.1.2 Global Cell Viability Assays Revenue Market Share by Players (2018-2023)

3.2 Global Cell Viability Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Cell Viability Assays, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Cell Viability Assays Market Concentration Ratio

3.4.1 Global Cell Viability Assays Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell Viability Assays Revenue in 2022

3.5 Global Key Players of Cell Viability Assays Head office and Area Served

3.6 Global Key Players of Cell Viability Assays, Product and Application

3.7 Global Key Players of Cell Viability Assays, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cell Viability Assays Breakdown Data by Type

4.1 Global Cell Viability Assays Historic Market Size by Type (2018-2023)

4.2 Global Cell Viability Assays Forecasted Market Size by Type (2024-2029)

5 Cell Viability Assays Breakdown Data by Application

5.1 Global Cell Viability Assays Historic Market Size by Application (2018-2023)

5.2 Global Cell Viability Assays Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Cell Viability Assays Market Size (2018-2029)

6.2 North America Cell Viability Assays Market Size by Type

6.2.1 North America Cell Viability Assays Market Size by Type (2018-2023)

6.2.2 North America Cell Viability Assays Market Size by Type (2024-2029)

6.2.3 North America Cell Viability Assays Market Share by Type (2018-2029)

6.3 North America Cell Viability Assays Market Size by Application

6.3.1 North America Cell Viability Assays Market Size by Application (2018-2023)

6.3.2 North America Cell Viability Assays Market Size by Application (2024-2029)

6.3.3 North America Cell Viability Assays Market Share by Application (2018-2029)

6.4 North America Cell Viability Assays Market Size by Country

6.4.1 North America Cell Viability Assays Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Cell Viability Assays Market Size by Country (2018-2023)

6.4.3 North America Cell Viability Assays Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Cell Viability Assays Market Size (2018-2029)

7.2 Europe Cell Viability Assays Market Size by Type

7.2.1 Europe Cell Viability Assays Market Size by Type (2018-2023)

7.2.2 Europe Cell Viability Assays Market Size by Type (2024-2029)

7.2.3 Europe Cell Viability Assays Market Share by Type (2018-2029)

7.3 Europe Cell Viability Assays Market Size by Application

7.3.1 Europe Cell Viability Assays Market Size by Application (2018-2023)

7.3.2 Europe Cell Viability Assays Market Size by Application (2024-2029)

7.3.3 Europe Cell Viability Assays Market Share by Application (2018-2029)

7.4 Europe Cell Viability Assays Market Size by Country

7.4.1 Europe Cell Viability Assays Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Cell Viability Assays Market Size by Country (2018-2023)

7.4.3 Europe Cell Viability Assays Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Cell Viability Assays Market Size (2018-2029)

8.2 China Cell Viability Assays Market Size by Type

8.2.1 China Cell Viability Assays Market Size by Type (2018-2023)

8.2.2 China Cell Viability Assays Market Size by Type (2024-2029)

8.2.3 China Cell Viability Assays Market Share by Type (2018-2029)

8.3 China Cell Viability Assays Market Size by Application

8.3.1 China Cell Viability Assays Market Size by Application (2018-2023)

8.3.2 China Cell Viability Assays Market Size by Application (2024-2029)

8.3.3 China Cell Viability Assays Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Cell Viability Assays Market Size (2018-2029)

9.2 Asia Cell Viability Assays Market Size by Type

9.2.1 Asia Cell Viability Assays Market Size by Type (2018-2023)

9.2.2 Asia Cell Viability Assays Market Size by Type (2024-2029)

9.2.3 Asia Cell Viability Assays Market Share by Type (2018-2029)

9.3 Asia Cell Viability Assays Market Size by Application

9.3.1 Asia Cell Viability Assays Market Size by Application (2018-2023)

9.3.2 Asia Cell Viability Assays Market Size by Application (2024-2029)

9.3.3 Asia Cell Viability Assays Market Share by Application (2018-2029)

9.4 Asia Cell Viability Assays Market Size by Region

9.4.1 Asia Cell Viability Assays Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Cell Viability Assays Market Size by Region (2018-2023)

9.4.3 Asia Cell Viability Assays Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Cell Viability Assays Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Type

10.2.1 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Cell Viability Assays Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Application

10.3.1 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Cell Viability Assays Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country

10.4.1 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Cell Viability Assays Introduction

11.1.4 Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2018-2023)

11.1.5 Thermo Fisher Scientific Recent Developments

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Cell Viability Assays Introduction

11.2.4 Merck Revenue in Cell Viability Assays Business (2018-2023)

11.2.5 Merck Recent Developments

11.3 Bio-Rad

11.3.1 Bio-Rad Company Details

11.3.2 Bio-Rad Business Overview

11.3.3 Bio-Rad Cell Viability Assays Introduction

11.3.4 Bio-Rad Revenue in Cell Viability Assays Business (2018-2023)

11.3.5 Bio-Rad Recent Developments

11.4 GE

11.4.1 GE Company Details

11.4.2 GE Business Overview

11.4.3 GE Cell Viability Assays Introduction

11.4.4 GE Revenue in Cell Viability Assays Business (2018-2023)

11.4.5 GE Recent Developments

11.5 Danaher

11.5.1 Danaher Company Details

11.5.2 Danaher Business Overview

11.5.3 Danaher Cell Viability Assays Introduction

11.5.4 Danaher Revenue in Cell Viability Assays Business (2018-2023)

11.5.5 Danaher Recent Developments

11.6 BD

11.6.1 BD Company Details

11.6.2 BD Business Overview

11.6.3 BD Cell Viability Assays Introduction

11.6.4 BD Revenue in Cell Viability Assays Business (2018-2023)

11.6.5 BD Recent Developments

11.7 PerkinElmer

11.7.1 PerkinElmer Company Details

11.7.2 PerkinElmer Business Overview

11.7.3 PerkinElmer Cell Viability Assays Introduction

11.7.4 PerkinElmer Revenue in Cell Viability Assays Business (2018-2023)

11.7.5 PerkinElmer Recent Developments

11.8 Promega

11.8.1 Promega Company Details

11.8.2 Promega Business Overview

11.8.3 Promega Cell Viability Assays Introduction

11.8.4 Promega Revenue in Cell Viability Assays Business (2018-2023)

11.8.5 Promega Recent Developments

11.9 Biotium

11.9.1 Biotium Company Details

11.9.2 Biotium Business Overview

11.9.3 Biotium Cell Viability Assays Introduction

11.9.4 Biotium Revenue in Cell Viability Assays Business (2018-2023)

11.9.5 Biotium Recent Developments

11.10 Abcam

11.10.1 Abcam Company Details

11.10.2 Abcam Business Overview

11.10.3 Abcam Cell Viability Assays Introduction

11.10.4 Abcam Revenue in Cell Viability Assays Business (2018-2023)

11.10.5 Abcam Recent Developments

11.11 Creative Bioarray

11.11.1 Creative Bioarray Company Details

11.11.2 Creative Bioarray Business Overview

11.11.3 Creative Bioarray Cell Viability Assays Introduction

11.11.4 Creative Bioarray Revenue in Cell Viability Assays Business (2018-2023)

11.11.5 Creative Bioarray Recent Developments

11.12 Biotek Instruments

11.12.1 Biotek Instruments Company Details

11.12.2 Biotek Instruments Business Overview

11.12.3 Biotek Instruments Cell Viability Assays Introduction

11.12.4 Biotek Instruments Revenue in Cell Viability Assays Business (2018-2023)

11.12.5 Biotek Instruments Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

PerkinElmer Inc

Merck

List of Tables

Table 1. Global Cell Viability Assays Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Human Cells

Table 3. Key Players of Microbial Cells

Table 4. Key Players of Animal Cells

Table 5. Global Cell Viability Assays Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 6. Global Cell Viability Assays Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 7. Global Cell Viability Assays Market Size by Region (2018-2023) & (US$ Million)

Table 8. Global Cell Viability Assays Market Share by Region (2018-2023)

Table 9. Global Cell Viability Assays Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 10. Global Cell Viability Assays Market Share by Region (2024-2029)

Table 11. Cell Viability Assays Market Trends

Table 12. Cell Viability Assays Market Drivers

Table 13. Cell Viability Assays Market Challenges

Table 14. Cell Viability Assays Market Restraints

Table 15. Global Cell Viability Assays Revenue by Players (2018-2023) & (US$ Million)

Table 16. Global Cell Viability Assays Revenue Share by Players (2018-2023)

Table 17. Global Top Cell Viability Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2022)

Table 18. Global Cell Viability Assays Industry Ranking 2021 VS 2022 VS 2023

Table 19. Global 5 Largest Players Market Share by Cell Viability Assays Revenue (CR5 and HHI) & (2018-2023)

Table 20. Global Key Players of Cell Viability Assays, Headquarters and Area Served

Table 21. Global Key Players of Cell Viability Assays, Product and Application

Table 22. Global Key Players of Cell Viability Assays, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)

Table 25. Global Cell Viability Assays Revenue Market Share by Type (2018-2023)

Table 26. Global Cell Viability Assays Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 27. Global Cell Viability Assays Revenue Market Share by Type (2024-2029)

Table 28. Global Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)

Table 29. Global Cell Viability Assays Revenue Share by Application (2018-2023)

Table 30. Global Cell Viability Assays Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 31. Global Cell Viability Assays Revenue Share by Application (2024-2029)

Table 32. North America Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)

Table 33. North America Cell Viability Assays Market Size by Type (2024-2029) & (US$ Million)

Table 34. North America Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)

Table 35. North America Cell Viability Assays Market Size by Application (2024-2029) & (US$ Million)

Table 36. North America Cell Viability Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. North America Cell Viability Assays Market Size by Country (2018-2023) & (US$ Million)

Table 38. North America Cell Viability Assays Market Size by Country (2024-2029) & (US$ Million)

Table 39. Europe Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)

Table 40. Europe Cell Viability Assays Market Size by Type (2024-2029) & (US$ Million)

Table 41. Europe Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)

Table 42. Europe Cell Viability Assays Market Size by Application (2024-2029) & (US$ Million)

Table 43. Europe Cell Viability Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. Europe Cell Viability Assays Market Size by Country (2018-2023) & (US$ Million)

Table 45. Europe Cell Viability Assays Market Size by Country (2024-2029) & (US$ Million)

Table 46. China Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)

Table 47. China Cell Viability Assays Market Size by Type (2024-2029) & (US$ Million)

Table 48. China Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)

Table 49. China Cell Viability Assays Market Size by Application (2024-2029) & (US$ Million)

Table 50. Asia Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)

Table 51. Asia Cell Viability Assays Market Size by Type (2024-2029) & (US$ Million)

Table 52. Asia Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)

Table 53. Asia Cell Viability Assays Market Size by Application (2024-2029) & (US$ Million)

Table 54. Asia Cell Viability Assays Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 55. Asia Cell Viability Assays Market Size by Region (2018-2023) & (US$ Million)

Table 56. Asia Cell Viability Assays Market Size by Region (2024-2029) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Type (2024-2029) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Application (2024-2029) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Cell Viability Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 62. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country (2018-2023) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country (2024-2029) & (US$ Million)

Table 64. Thermo Fisher Scientific Company Details

Table 65. Thermo Fisher Scientific Business Overview

Table 66. Thermo Fisher Scientific Cell Viability Assays Product

Table 67. Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 68. Thermo Fisher Scientific Recent Developments

Table 69. Merck Company Details

Table 70. Merck Business Overview

Table 71. Merck Cell Viability Assays Product

Table 72. Merck Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 73. Merck Recent Developments

Table 74. Bio-Rad Company Details

Table 75. Bio-Rad Business Overview

Table 76. Bio-Rad Cell Viability Assays Product

Table 77. Bio-Rad Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 78. Bio-Rad Recent Developments

Table 79. GE Company Details

Table 80. GE Business Overview

Table 81. GE Cell Viability Assays Product

Table 82. GE Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 83. GE Recent Developments

Table 84. Danaher Company Details

Table 85. Danaher Business Overview

Table 86. Danaher Cell Viability Assays Product

Table 87. Danaher Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 88. Danaher Recent Developments

Table 89. BD Company Details

Table 90. BD Business Overview

Table 91. BD Cell Viability Assays Product

Table 92. BD Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 93. BD Recent Developments

Table 94. PerkinElmer Company Details

Table 95. PerkinElmer Business Overview

Table 96. PerkinElmer Cell Viability Assays Product

Table 97. PerkinElmer Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 98. PerkinElmer Recent Developments

Table 99. Promega Company Details

Table 100. Promega Business Overview

Table 101. Promega Cell Viability Assays Product

Table 102. Promega Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 103. Promega Recent Developments

Table 104. Biotium Company Details

Table 105. Biotium Business Overview

Table 106. Biotium Cell Viability Assays Product

Table 107. Biotium Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 108. Biotium Recent Developments

Table 109. Abcam Company Details

Table 110. Abcam Business Overview

Table 111. Abcam Cell Viability Assays Product

Table 112. Abcam Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 113. Abcam Recent Developments

Table 114. Creative Bioarray Company Details

Table 115. Creative Bioarray Business Overview

Table 116. Creative Bioarray Cell Viability Assays Product

Table 117. Creative Bioarray Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 118. Creative Bioarray Recent Developments

Table 119. Biotek Instruments Company Details

Table 120. Biotek Instruments Business Overview

Table 121. Biotek Instruments Cell Viability Assays Product

Table 122. Biotek Instruments Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)

Table 123. Biotek Instruments Recent Developments

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cell Viability Assays Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Cell Viability Assays Market Share by Type: 2022 VS 2029

Figure 3. Human Cells Features

Figure 4. Microbial Cells Features

Figure 5. Animal Cells Features

Figure 6. Global Cell Viability Assays Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 7. Global Cell Viability Assays Market Share by Application: 2022 VS 2029

Figure 8. Pharmaceutical and Biotechnology Companies Case Studies

Figure 9. Academic and Research Institutes Case Studies

Figure 10. Hospital and Diagnostic Laboratories Case Studies

Figure 11. Others Case Studies

Figure 12. Cell Viability Assays Report Years Considered

Figure 13. Global Cell Viability Assays Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 14. Global Cell Viability Assays Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Cell Viability Assays Market Share by Region: 2022 VS 2029

Figure 16. Global Cell Viability Assays Market Share by Players in 2022

Figure 17. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2022)

Figure 18. The Top 10 and 5 Players Market Share by Cell Viability Assays Revenue in 2022

Figure 19. North America Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. North America Cell Viability Assays Market Share by Type (2018-2029)

Figure 21. North America Cell Viability Assays Market Share by Application (2018-2029)

Figure 22. North America Cell Viability Assays Market Share by Country (2018-2029)

Figure 23. United States Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Canada Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. Europe Cell Viability Assays Market Size YoY (2018-2029) & (US$ Million)

Figure 26. Europe Cell Viability Assays Market Share by Type (2018-2029)

Figure 27. Europe Cell Viability Assays Market Share by Application (2018-2029)

Figure 28. Europe Cell Viability Assays Market Share by Country (2018-2029)

Figure 29. Germany Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. France Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. U.K. Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Italy Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Russia Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Nordic Countries Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. China Cell Viability Assays Market Size YoY (2018-2029) & (US$ Million)

Figure 36. China Cell Viability Assays Market Share by Type (2018-2029)

Figure 37. China Cell Viability Assays Market Share by Application (2018-2029)

Figure 38. Asia Cell Viability Assays Market Size YoY (2018-2029) & (US$ Million)

Figure 39. Asia Cell Viability Assays Market Share by Type (2018-2029)

Figure 40. Asia Cell Viability Assays Market Share by Application (2018-2029)

Figure 41. Asia Cell Viability Assays Market Share by Region (2018-2029)

Figure 42. Japan Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. South Korea Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. China Taiwan Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Southeast Asia Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. India Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Australia Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Cell Viability Assays Market Size YoY (2018-2029) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Cell Viability Assays Market Share by Type (2018-2029)

Figure 50. Middle East, Africa, and Latin America Cell Viability Assays Market Share by Application (2018-2029)

Figure 51. Middle East, Africa, and Latin America Cell Viability Assays Market Share by Country (2018-2029)

Figure 52. Brazil Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Mexico Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Turkey Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Saudi Arabia Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Israel Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. GCC Countries Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 59. Merck Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 60. Bio-Rad Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 61. GE Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 62. Danaher Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 63. BD Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 64. PerkinElmer Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 65. Promega Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 66. Biotium Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 67. Abcam Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 68. Creative Bioarray Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 69. Biotek Instruments Revenue Growth Rate in Cell Viability Assays Business (2018-2023)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Cell Viability Assays Market Insights, Forecast to 2029

Published Date: May 2023

Report Code: QYRE-Othe-370

Global Cell Viability Assays Market Insights, Forecast to 2029

FEATURED COMPANIES

Cell Viability Assays Market Size

Cell Viability Assays Market

Scope of Cell Viability Assays Market Report

Chapter Outline

FEATURED COMPANIES

RELATED REPORTS